Dr. Owonikoko on Talazoparib in HRRD-Positive Stage IV Squamous Cell Lung Cancer

Leggi l'articolo originale


Cancer Network spoke with Taofeek Kunle Owonikoko, MD, PhD, of Emory University, about talazoparib for patients with HRRD-positive stage IV squamous cell lung cancer.

Lascia un commento